Florez-Polo MC, Delgado-Salcedo CL, Chávez-Betancourth G, Gómez-Urrego JF

Language: Spanish
References: 21
Page: 82-86
PDF size: 1924.68 Kb.

ABSTRACT

Introduction: gastric adenocarcinoma (GAC) is rare in the pediatric population, representing less than 0.1% of cases. The low incidence and nonspecific symptoms delay diagnosis. The aim of this report is to describe a case of an adolescent with diffuse GAC. Case description: a 17-year-old female patient presented with abdominal pain, vomiting, weight loss, and constipation. Imaging studies revealed liver lesions, diffuse gastric thickening, and bilateral ovarian masses. Endoscopy with biopsy confirmed diffuse, poorly cohesive giant cell gastric carcinoma with signet ring cells. Hepatic, peritoneal, bilateral ovarian (Krukenberg type), and brain metastases were confirmed. She required multiple surgical interventions and intensive care management; however, she rapidly progressed to multiple organ failure and died. Conclusions: GAC in children and adolescents presents a diagnostic and therapeutic challenge. This case highlights the importance of early suspicion as part of the differential diagnosis in patients with gastrointestinal symptoms.

REFERENCES

1. Rojas E, Morales J, Sánchez P, Gutiérrez L, Ramírez C. Gastric adenocarcinoma in a 13-year-old adolescent associated to Helicobacter pylori infection. Gastroenterol Latinoam. 2024; 35(3): 175-179.

2. Subbiah V, Varadhachary G, Herzog CE, Wu W. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer. 2011; 57(4): 524-527.

3. Abele M, Grabner L, Block A, Agaimy A, Kratz C, Metzler M et al. Epidemiology and characteristics of gastric carcinoma in childhood: an analysis of data from population-based and clinical cancer registries. Cancers (Basel). 2023; 15(1): 317.

4. Attard TM, Omar U, Glynn EF, Stoecklein N, St Peter SD, Thomson MA. Gastric cancer in the pediatric population: a multicenter cross-sectional analysis of presentation and coexisting comorbidities. J Cancer Res Clin Oncol. 2023; 149(5): 1261-1272.

5. Lin CH, Lin WC, Lai IH, Wu SF, Wu KH, Chen AC. Pediatric gastric cancer presenting with massive ascites. World J Gastroenterol. 2015; 21(11): 3409-3413.

6. De Anda-Coronado A, Treviño-Arizmendi CJ, Elizondo-Jasso JH, Muñoz-Maldonado GE, Treviño Lozano MA, Ortiz-Meza IA. Presentación inusual de adenocarcinoma gástrico en pacientes pediátricos: reporte de un caso. Gac Mex Oncol. 2023; 22(Supl 1): 32-35. doi: 10.24875/j.gamo.22000071.

7. Tessler RA, Dellinger M, Richards MK, Goldin AB, Beierle EA, Doski JJ et al. Pediatric gastric adenocarcinoma: a National Cancer Data Base review. J Pediatr Surg. 2019; 54(5): 1029-1034.

8. Witt L, Pillay Y, Sabaratnam RM, Bigsby RJ. De novo adolescent gastric carcinoma: a first case report in Saskatchewan, Canada. J Surg Case Rep. 2020; 2020(8): rjaa249.

9. Altay D, Karaman ZF, Ozcan A, Deniz K, Unal E, Pat?roglu T et al. Two pediatric cases of gastric adenocarcinoma and review of the literature. Erciyes Med J. 2021; 43(3): 296-299.

10. Cislo M, Filip AA, Arnold OGJ, Cisel B, Rawicz-Pruszy?ski K, Skierucha M et al. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology. Oncotarget. 2018; 9(27): 19427-19442.

11. Corso G, Comelli G, Veronesi P, Bianchi B, Petitto S, Polizzi A et al. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women. J Cancer Res Clin Oncol. 2023; 149(17): 16147-16155. doi: 10.1007/s00432-023-05318-5.

12. Singh AD, Gupta A, Mehta N, Heald B, Macaron C, Liska D et al. Occurrence of gastric cancer in patients with juvenile polyposis syndrome: a systematic review and meta-analysis. Gastrointest Endosc. 2023; 97(3): 407-414.e1. doi: 10.1016/j.gie.2022.10.026.

13. Li Y, Hahn AI, Laszkowska M, Jiang F, Zauber AG, Leung WK. Clinicopathological characteristics and risk factors of young-onset gastric carcinoma: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2024; 15(6): e1.

14. Okuda M, Nomura K, Kato M, Lin Y, Mabe K, Miyamoto R et al. Gastric cancer in children and adolescents in Japan. Pediatr Int. 2019; 61(1): 80-86.

15. Bustamante RH, Romero W. Gastric adenocarcinoma in childhood: a case report and a literature review. Cir Pediatr. 2021; 34(3): 151-155.

16. Sobh MJ, Al Jayyousi OA, Mahasna A, Sobh RJ. Pediatric gastric adenocarcinoma presenting as hip pain. Cureus. 2023; 15(2): e34651.

17. Agnes A, Biondi A, Ricci R, Gallotta V, D'Ugo D, Persiani R. Krukenberg tumors: Seed, route and soil. Surg Oncol. 2017; 26(4): 438-445. doi: 10.1016/j.suronc.2017.09.001.

18. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW et al. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016; 29(7): 772-784.

19. Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016; 11(5): 2959-2964.

20. Van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015; 52(6): 361-374.

21. Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW et al. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with advanced gastric or gastroesophageal junction adenocarcinoma: the KEYNOTE-062 randomized clinical trial. JAMA Oncol. 2020; 6(10): 1571-1580.